Sign in

CIK 0001521036 · Large accelerated filer

Lantheus Holdings, Inc.

Sign in to watch
Ticker
LNTH
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
352318913
Phone
978 671-8001
Business address
201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
Former names
Lantheus MI Holdings, Inc.
  1. 4 Grant or award See Remarks acquired 20,966 shares (grant or award)
  2. 4 Shares withheld for taxes CFO and Treasurer gave up 1,182 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Accounting Officer gave up 133 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Commercial Officer gave up 595 shares (to pay taxes)
  5. 4 Shares withheld for taxes See Remarks gave up 8,259 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Commercial Officer gave up 3,336 shares (to pay taxes)
  7. 4 Shares withheld for taxes CFO and Treasurer gave up 10,652 shares (to pay taxes)
  8. 4 Shares withheld for taxes Executive Chair and CEO gave up 41,916 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Commercial Officer gave up 724 shares (to pay taxes)
  10. 4 Grant or award Executive Chair acquired 14,285 shares (grant or award)
  11. 4 Shares withheld for taxes CFO and Treasurer gave up 727 shares (to pay taxes)
  12. 4 Open-market sale Member of a Group Owning 10% sold 3,406,000 shares at an average $56.14 ($191,213,690)
  13. 4 Open-market sale 10% owner sold 3,406,000 shares at an average $56.14 ($191,213,690)
  14. 4 Shares withheld for taxes Chief Accounting Officer gave up 463 shares (to pay taxes)
  15. 4 Grant or award See Remarks acquired 14,765 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 4 Planned sale President sold 3,060 shares at $53.57 ($163,924)
  20. 4 Shares withheld for taxes President gave up 518 shares (to pay taxes)

Page 2 of 30 · 598 filings